Intel (INTC) stock sank 1.45% even though analysts told Reuters that the ... after …
StockMarketWire.com - GlaxoSmithKline said Thursday that its two-drug treatment for HIV, met its primary goal after demonstrating the ability to control HIV. The studies met their primary endpoint for non-inferiority, a standard measure …
Hargreaves Lansdown may not share ShareCast's (powered by Digital Look) views. (Sharecast News) - GlaxoSmithKline shares were given a double boost on Thursday as the drugmaker said its two-drug treatment for HIV had met main …
(Reuters) - GlaxoSmithKline's two-drug treatment for HIV, the virus that causes AIDS, met its main goal in late stage studies, scoring key points in its rivalry with Gilead in the medical field. The combination of dolutegravir and lamivudine …